{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:15:08Z","timestamp":1789578908731,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009863","name":"Neuroendocrine Tumor Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009863","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Small intestinal neuroendocrine tumors (SI-NETs) are the most common neoplasms of the small bowel. The majority of tumors are located in the distal ileum with a high incidence of multiple synchronous primary tumors. Even though up to 50% of SI-NET patients are diagnosed with multifocal disease, the mechanisms underlying multiple synchronous lesions remain elusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed whole genome sequencing of 75 de-identified synchronous primary tumors, 15 metastases, and corresponding normal samples from 13 patients with multifocal ileal NETs to identify recurrent somatic genomic alterations, frequently affected signaling pathways, and shared mutation signatures among multifocal SI-NETs. Additionally, we carried out chromosome mapping of the most recurrent copy-number alterations identified to determine which parental allele had been affected in each tumor and assessed the clonal relationships of the tumors within each patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Absence of shared somatic variation between the synchronous primary tumors within each patient was observed, indicating that these tumors develop independently. Although recurrent copy-number alterations were identified, additional chromosome mapping revealed that tumors from the same patient can gain or lose different parental alleles. In addition to the previously reported\n                      <jats:italic>CDKN1B<\/jats:italic>\n                      loss-of-function mutations, we observed potential loss-of-function gene alterations in\n                      <jats:italic>TNRC6B<\/jats:italic>\n                      , a candidate tumor suppressor gene in a small subset of ileal NETs. Furthermore, we show that multiple metastases in the same patient can originate from either one or several primary tumors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study demonstrates major genomic diversity among multifocal ileal NETs, highlighting the need to identify and remove all primary tumors, which have the potential to metastasize, and the need for optimized targeted treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13073-022-01083-1","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T09:04:14Z","timestamp":1659517454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors"],"prefix":"10.1186","volume":"14","author":[{"given":"Netta","family":"M\u00e4kinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace E.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrissie","family":"Thirlwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Nakakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9133-8108","authenticated-orcid":false,"given":"Matthew","family":"Meyerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"1083_CR1","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063\u201372. https:\/\/doi.org\/10.1200\/JCO.2007.15.4377.","journal-title":"J Clin Oncol"},{"key":"1083_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","volume":"249","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249:63\u201371. https:\/\/doi.org\/10.1097\/SLA.0b013e31818e4641.","journal-title":"Ann Surg"},{"key":"1083_CR3","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s00268-010-0519-z","volume":"34","author":"K Landerholm","year":"2010","unstructured":"Landerholm K, Falkmer S, J\u00e4rhult J. Epidemiology of small bowel carcinoids in a defined population. World J Surg. 2010;34:1500\u20135. https:\/\/doi.org\/10.1007\/s00268-010-0519-z.","journal-title":"World J Surg"},{"key":"1083_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/01.sla.0000129342.67174.67","volume":"240","author":"MA Maggard","year":"2004","unstructured":"Maggard MA, O\u2019Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240:117\u201322. https:\/\/doi.org\/10.1097\/01.sla.0000129342.67174.67.","journal-title":"Ann Surg"},{"key":"1083_CR5","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/j.1572-0241.2007.01185.x","volume":"102","author":"IM Modlin","year":"2007","unstructured":"Modlin IM, Champaneria MC, Chan AK, Kidd M. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol. 2007;102:1464\u201373. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01185.x.","journal-title":"Am J Gastroenterol"},{"key":"1083_CR6","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934\u201359. https:\/\/doi.org\/10.1002\/cncr.11105.","journal-title":"Cancer"},{"key":"1083_CR7","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1172\/JCI67963","volume":"123","author":"MS Banck","year":"2013","unstructured":"Banck MS, Kanwar R, Kulkarni AA, Boora GK, Metge F, Kipp BR, et al. The genomic landscape of small intestine neuroendocrine tumors. J Clin Invest. 2013;123:2502\u20138. https:\/\/doi.org\/10.1172\/JCI67963.","journal-title":"J Clin Invest"},{"key":"1083_CR8","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/ng.2821","volume":"45","author":"JM Francis","year":"2013","unstructured":"Francis JM, Kiezun A, Ramos AH, Serra S, Pedamallu CS, Qian ZR, et al. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. Nat Genet. 2013;45:1483\u20136. https:\/\/doi.org\/10.1038\/ng.2821.","journal-title":"Nat Genet"},{"key":"1083_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1158\/1078-0432.CCR-15-0373","volume":"22","author":"A Karpathakis","year":"2016","unstructured":"Karpathakis A, Dibra H, Pipinikas C, Feber A, Morris T, Francis J, et al. Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor. Clin Cancer Res. 2016;22:250\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0373.","journal-title":"Clin Cancer Res"},{"key":"1083_CR10","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1038\/s41598-018-22115-0","volume":"8","author":"D Walter","year":"2018","unstructured":"Walter D, Harter PN, Battke F, Winkelmann R, Schneider M, Holzer K, et al. Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors. Sci Rep. 2018;8:3811. https:\/\/doi.org\/10.1038\/s41598-018-22115-0.","journal-title":"Sci Rep"},{"key":"1083_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00428-018-2450-x","volume":"473","author":"M Simbolo","year":"2018","unstructured":"Simbolo M, Vicentini C, Mafficini A, Fassan M, Pedron S, Corbo V, et al. Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine. Virchows Arch. 2018;473:709\u201317. https:\/\/doi.org\/10.1007\/s00428-018-2450-x.","journal-title":"Virchows Arch"},{"key":"1083_CR12","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64136-3","volume":"158","author":"S Kyt\u00f6l\u00e4","year":"2001","unstructured":"Kyt\u00f6l\u00e4 S, H\u00f6\u00f6g A, Nord B, Cedermark B, Frisk T, Larsson C, et al. Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids. Am J Pathol. 2001;158:1803\u20138. https:\/\/doi.org\/10.1016\/S0002-9440(10)64136-3.","journal-title":"Am J Pathol"},{"key":"1083_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/ijc.1276","volume":"92","author":"RM L\u00f6llgen","year":"2001","unstructured":"L\u00f6llgen RM, Hessman O, Szabo E, Westin G, Akerstr\u00f6m G. Chromosome 18 deletions are common events in classical midgut carcinoid tumors. Int J Cancer. 2001;92:812\u20135. https:\/\/doi.org\/10.1002\/ijc.1276 (PMID: 11351300).","journal-title":"Int J Cancer"},{"key":"1083_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/gcc.20834","volume":"50","author":"JL Cunningham","year":"2011","unstructured":"Cunningham JL, D\u00edaz de St\u00e5hl T, Sj\u00f6blom T, Westin G, Dumanski JP, Janson ET. Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors. Genes Chromosomes Cancer. 2011;50:82\u201394. https:\/\/doi.org\/10.1002\/gcc.20834.","journal-title":"Genes Chromosomes Cancer."},{"issue":"Suppl 3","key":"1083_CR15","doi-asserted-by":"publisher","first-page":"S1428","DOI":"10.1245\/s10434-014-4351-9","volume":"22","author":"J Crona","year":"2015","unstructured":"Crona J, Gustavsson T, Norl\u00e9n O, Edfeldt K, \u00c5kerstr\u00f6m T, Westin G, et al. Somatic mutations and genetic heterogeneity at the CDKN1B locus in small intestinal neuroendocrine tumors. Ann Surg Oncol. 2015;22(Suppl 3):S1428\u201335. https:\/\/doi.org\/10.1245\/s10434-014-4351-9.","journal-title":"Ann Surg Oncol"},{"key":"1083_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","volume":"575","author":"P Priestley","year":"2019","unstructured":"Priestley P, Baber J, Lolkema MP, Steeghs N, de Bruijn E, Shale C, et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature. 2019;575:210\u20136. https:\/\/doi.org\/10.1038\/s41586-019-1689-y.","journal-title":"Nature"},{"key":"1083_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5858\/arpa.2015-0314-RA","volume":"140","author":"JY Kim","year":"2016","unstructured":"Kim JY, Hong SM. Recent updates on neuroendocrine tumors from the gastrointestinal and pancreatobiliary tracts. Arch Pathol Lab Med. 2016;140:437\u201348. https:\/\/doi.org\/10.5858\/arpa.2015-0314-RA.","journal-title":"Arch Pathol Lab Med"},{"key":"1083_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11605-017-3586-8","volume":"22","author":"A Gangi","year":"2018","unstructured":"Gangi A, Siegel E, Barmparas G, Lo S, Jamil LH, Hendifar A, et al. Multifocality in small bowel neuroendocrine tumors. J Gastrointest Surg. 2018;22:303\u20139. https:\/\/doi.org\/10.1007\/s11605-017-3586-8.","journal-title":"J Gastrointest Surg"},{"key":"1083_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/gcc.22850","volume":"59","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, M\u00e4kinen N, Kasai Y, Kim GE, Diosdado B, Nakakura E, et al. Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors. Genes Chromosomes Cancer. 2020;59:535\u20139. https:\/\/doi.org\/10.1002\/gcc.22850.","journal-title":"Genes Chromosomes Cancer"},{"key":"1083_CR20","doi-asserted-by":"publisher","unstructured":"Elias E, Ardalan A, Lindberg M, Reinsbach S, Muth A, Nilsson O, et al. Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine. bioRxiv. 2020 https:\/\/doi.org\/10.1101\/2020.05.06.080499 version 3","DOI":"10.1101\/2020.05.06.080499"},{"key":"1083_CR21","unstructured":"Digestive System Tumours WHO Classification of Tumours. 5th ed. Edited by the WHO Classification of Tumours Editorial Board. Lyon: International Agency for Research on Cancer; 2019."},{"key":"1083_CR22","doi-asserted-by":"crossref","unstructured":"M\u00e4kinen N, Zhou M, Zhang Z, Kasai Y, Perez E, Kim GE, et al. Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors. EGAS00001006294, European Genome-phenome Archive (EGA). 2022. https:\/\/ega-archive.org\/studies\/EGAS00001006294. Accessed 25 Jun 2022.","DOI":"10.1186\/s13073-022-01083-1"},{"key":"1083_CR23","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754\u201360. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324.","journal-title":"Bioinformatics"},{"key":"1083_CR24","unstructured":"Picard. https:\/\/broadinstitute.github.io\/picard\/"},{"key":"1083_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43:491\u20138. https:\/\/doi.org\/10.1038\/ng.806.","journal-title":"Nat Genet"},{"key":"1083_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31:213\u20139. https:\/\/doi.org\/10.1038\/nbt.2514.","journal-title":"Nat Biotechnol"},{"key":"1083_CR27","unstructured":"Van der Auwera, G.A. and O'Connor, B.D. Genomics in the cloud: using Docker, GATK, and WDL in Terra. 1st ed. Sebastopol, MA: O'Reilly Media; 2020."},{"key":"1083_CR28","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders CT, Wong WS, Swamy S, Becq J, Murray LJ, Cheetham RK. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics. 2012;28:1811\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/bts271.","journal-title":"Bioinformatics"},{"key":"1083_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1101\/gr.221028.117","volume":"28","author":"JA Wala","year":"2018","unstructured":"Wala JA, Bandopadhayay P, Greenwald NF, O\u2019Rourke R, Sharpe T, Stewart C, et al. SvABA: genome-wide detection of structural variants and indels by local assembly. Genome Res. 2018;28:581\u201391. https:\/\/doi.org\/10.1101\/gr.221028.117.","journal-title":"Genome Res"},{"key":"1083_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014;505:495\u2013501. https:\/\/doi.org\/10.1038\/nature12912.","journal-title":"Nature"},{"key":"1083_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cell.2016.12.025","volume":"168","author":"M Imielinski","year":"2017","unstructured":"Imielinski M, Guo G, Meyerson M. Insertions and deletions target lineage-defining genes in human cancers. Cell. 2017;168:460-472.e14. https:\/\/doi.org\/10.1016\/j.cell.2016.12.025.","journal-title":"Cell"},{"key":"1083_CR32","doi-asserted-by":"publisher","first-page":"D939","DOI":"10.1093\/nar\/gkaa980","volume":"49","author":"S Tweedie","year":"2021","unstructured":"Tweedie S, Braschi B, Gray K, Jones TEM, Seal RL, Yates B, et al. Genenames.org: the HGNC and VGNC resources in 2021. Nucleic Acids Res. 2021;49:D939\u201346. https:\/\/doi.org\/10.1093\/nar\/gkaa980.","journal-title":"Nucleic Acids Res."},{"key":"1083_CR33","unstructured":"RepeatMasker. http:\/\/repeatmasker.org\/"},{"key":"1083_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","volume":"18","author":"A Fabregat","year":"2017","unstructured":"Fabregat A, Sidiropoulos K, Viteri G, Forner O, Marin-Garcia P, Arnau V, et al. Reactome pathway analysis: a high-performance in-memory approach. BMC Bioinformatics. 2017;18:142. https:\/\/doi.org\/10.1186\/s12859-017-1559-2.","journal-title":"BMC Bioinformatics"},{"key":"1083_CR35","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1186\/s12864-019-6041-2","volume":"20","author":"EN Bergstrom","year":"2019","unstructured":"Bergstrom EN, Huang MN, Mahto U, Barnes M, Stratton MR, Rozen SG, et al. SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events. BMC Genomics. 2019;20:685. https:\/\/doi.org\/10.1186\/s12864-019-6041-2.","journal-title":"BMC Genomics"},{"key":"1083_CR36","unstructured":"AlexandrovLab\/SigProfilerExtractor. https:\/\/github.com\/AlexandrovLab\/SigProfilerExtractor"},{"key":"1083_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, et al. The repertoire of mutational signatures in human cancer. Nature. 2020;578:94\u2013101. https:\/\/doi.org\/10.1038\/s41586-020-1943-3.","journal-title":"Nature"},{"key":"1083_CR38","doi-asserted-by":"publisher","DOI":"10.1101\/201178","author":"R Poplin","year":"2017","unstructured":"Poplin R, Ruano-Rubio V, DePristo MA, Fennell TJ, Carneiro MO, Van der Auwera GA, et al. Scaling accurate genetic variant discovery to tens of thousands of samples. bioRxiv. 2017. https:\/\/doi.org\/10.1101\/201178.","journal-title":"bioRxiv"},{"key":"1083_CR39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-020-2493-4","volume":"583","author":"JE Moore","year":"2020","unstructured":"ENCODE Project Consortium, Moore JE, Purcaro MJ, Pratt HE, Epstein CB, Shoresh N, et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature. 2020;583:699\u2013710. https:\/\/doi.org\/10.1038\/s41586-020-2493-4.","journal-title":"Nature."},{"key":"1083_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2121-6-3","volume":"6","author":"CA Patel","year":"2005","unstructured":"Patel CA, Ghiselli G. Hinderin, a five-domains protein including coiled-coil motifs that binds to SMC3. BMC Cell Biol. 2005;6:3. https:\/\/doi.org\/10.1186\/1471-2121-6-3.","journal-title":"BMC Cell Biol"},{"key":"1083_CR41","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1128\/MCB.21.4.1285-1296.2001","volume":"21","author":"AN Ladd","year":"2001","unstructured":"Ladd AN, Charlet N, Cooper TA. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol. 2001;21:1285\u201396. https:\/\/doi.org\/10.1128\/MCB.21.4.1285-1296.2001.","journal-title":"Mol Cell Biol"},{"key":"1083_CR42","doi-asserted-by":"publisher","first-page":"e11219","DOI":"10.7717\/peerj.11219","volume":"9","author":"Y Miao","year":"2021","unstructured":"Miao Y, Zhang H, Su B, Wang J, Quan W, Li Q, et al. Construction and validation of an RNA-binding protein-associated prognostic model for colorectal cancer. PeerJ. 2021;9:e11219. https:\/\/doi.org\/10.7717\/peerj.11219.","journal-title":"PeerJ"},{"key":"1083_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2021.101941","volume":"72","author":"CC Teerlink","year":"2021","unstructured":"Teerlink CC, Stevens J, Hernandez R, Facelli JC, Cannon-Albright LA. An intronic variant in the CELF4 gene is associated with risk for colorectal cancer. Cancer Epidemiol. 2021;72: 101941. https:\/\/doi.org\/10.1016\/j.canep.2021.101941.","journal-title":"Cancer Epidemiol"},{"key":"1083_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","volume":"20","author":"LFR Gebert","year":"2019","unstructured":"Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019;20:21\u201337. https:\/\/doi.org\/10.1038\/s41580-018-0045-7.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1083_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1158\/0008-5472.CAN-08-3464","volume":"69","author":"J Sun","year":"2009","unstructured":"Sun J, Zheng SL, Wiklund F, Isaacs SD, Li G, Wiley KE, et al. Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res. 2009;69:10\u20135. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3464.","journal-title":"Cancer Res"},{"key":"1083_CR46","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-06-3533","volume":"67","author":"S Chiosea","year":"2007","unstructured":"Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol RW, et al. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res. 2007;67:2345\u201350. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3533.","journal-title":"Cancer Res"},{"key":"1083_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1471-2407-13-99","volume":"13","author":"Y Murakami","year":"2013","unstructured":"Murakami Y, Tamori A, Itami S, Tanahashi T, Toyoda H, Tanaka M, et al. The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis. BMC Cancer. 2013;13:99. https:\/\/doi.org\/10.1186\/1471-2407-13-99.","journal-title":"BMC Cancer"},{"key":"1083_CR48","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1245\/s10434-017-6026-9","volume":"25","author":"EK Nakakura","year":"2018","unstructured":"Nakakura EK. Challenges staging neuroendocrine tumors of the pancreas, jejunum and ileum, and appendix. Ann Surg Oncol. 2018;25:591\u20133. https:\/\/doi.org\/10.1245\/s10434-017-6026-9.","journal-title":"Ann Surg Oncol"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01083-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-022-01083-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01083-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T08:51:32Z","timestamp":1676278292000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-022-01083-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1083"],"URL":"https:\/\/doi.org\/10.1186\/s13073-022-01083-1","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"assertion":[{"value":"18 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Each patient provided informed consent to participate in this study in accordance with the protocols approved by the Institutional Review Boards of the Dana-Farber Cancer Institute (IRB#: 17\u2013349) and the University of California San Francisco (IRB#: 13\u201312574). Research performed conformed to the principles of the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Meyerson declares the following general conflicts of interest: research support from Bayer, Ono, and Janssen; patent licensing royalties from Bayer and LabCorp; and serving as scientific advisory board member and consultant for Interline and Isabl. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}